 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ACTON, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing for substance abuse, proudly announces the appointment of Daniella Mehalik as...

Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance

ACTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a leading provider of hair testing for drugs of abuse, today announced financial results for the third...

Psychemedics Corporation Reports Third Quarter 2023 Financial Results

ACTON, Mass., Aug. 18, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the worlds largest provider of hair testing for drugs of abuse, announced the grant of inducement awards to its newly appointed President and Chief Executive Officer, Brian Hullinger, upon his entering into ...

Psychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ACTON, Mass., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world s largest provider of hair testing for drugs of abuse, today announced financial results for the...

Psychemedics Corporation Reports Second Quarter 2023 Financial Results

Brian Hullinger Will Succeed Ray Kubacki as CEO Effective August 17, 2023 Mr. Hullinger Brings 30 Years of Leadership Experience and a Proven Track Record of Driving Growth ACTON, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the worlds largest provider of hair ...

Psychemedics Corporation Announces CEO Succession Plan

On 5/24/23, Psychemedics Corp. (PMD) will trade ex-dividend, for its quarterly dividend of 0.07, payable on 6/8/23...

Reminder - Psychemedics (PMD) Goes Ex-Dividend Soon

The board of Psychemedics Corporation ( NASDAQ:PMD ) has announced that it will pay a dividend of $0.07 per share on...

Psychemedics (NASDAQ:PMD) Is Paying Out A Dividend Of $0.07

ACTON, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the worlds largest provider of hair testing for drugs of abuse, today announced financial results for the first quarter ended March 31, 2023, and the declaration of a cash dividend of $0.07 per share to be paid on...

Psychemedics Corporation Reports First Quarter 2023 Financial Results and Declares Cash Dividend

On 3/30/23, Psychemedics Corp. (PMD) will trade ex-dividend, for its quarterly dividend of 0.07, payable on 4/10/23...

Ex-Div Reminder for Psychemedics (PMD)

Psychemedics's Ex-Dividend Date Is Thursday, Here's What You Need To Know

Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. It offers workplace, school, and personal drug testing services. The company was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.

Market Cap	$17.35M
Volume (M)	465.00
52-Wk High	$6.75
52-Wk Low	$2.06

PMD Psychemedics Corp.

About

Feed

News

Sentiment

Earnings

Fundamentals

Sentiment

Message Volume

Community